CytRx's (CYTR) INNO-206 Receives Orphan Drug Designation from U.S. FDA
Tweet Send to a Friend
CytRx Corporation (Nasdaq: CYTR) reports its tumor-targeting pro-drug candidate INNO-206 has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
